Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) EBIT (2021 - 2025)

Historic EBIT for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to $38.4 million.

  • MDxHealth's EBIT rose 1082.5% to $38.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $146.7 million, marking a year-over-year increase of 1196.09%. This contributed to the annual value of -$24.7 million for FY2024, which is 953.27% up from last year.
  • As of Q3 2025, MDxHealth's EBIT stood at $38.4 million, which was up 1082.5% from $37.0 million recorded in Q2 2025.
  • MDxHealth's 5-year EBIT high stood at $38.4 million for Q3 2025, and its period low was $7.4 million during Q4 2021.
  • Over the past 5 years, MDxHealth's median EBIT value was $29.7 million (recorded in 2023), while the average stood at $26.3 million.
  • Its EBIT has fluctuated over the past 5 years, first skyrocketed by 21563.68% in 2022, then soared by 900.26% in 2025.
  • Quarter analysis of 5 years shows MDxHealth's EBIT stood at $7.4 million in 2021, then surged by 215.64% to $23.4 million in 2022, then skyrocketed by 35.28% to $31.6 million in 2023, then grew by 12.62% to $35.6 million in 2024, then increased by 7.72% to $38.4 million in 2025.
  • Its last three reported values are $38.4 million in Q3 2025, $37.0 million for Q2 2025, and $35.6 million during Q1 2025.